Nice research Toomes. Medipharm is the real deal and the big boys are waking up to it.This is just the beginning of massive gains for LABS. Hopefully JC does not divest these shares until the MOIC is 20:1!
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game